Third Department of Obstetrics and Gynaecology, Faculty of Health Sciences,School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Department of Perinatal Medicine, Obstetrics and Gynecology, Perinatal Medicine Foundation and Istanbul University-Cerrahpasa, Istanbul, Turkey.
J Perinat Med. 2022 Mar 11;50(4):375-385. doi: 10.1515/jpm-2022-0066. Print 2022 May 25.
This practice guideline follows the mission of the World Association of Perinatal Medicine in collaboration with the Perinatal Medicine Foundation, bringing together groups and individuals throughout the world, with the goal of improving the use of antenatal corticosteroids (ACS) for fetal maturation. In fact, this document provides further guidance for healthcare practitioners on the appropriate use of ACS with the aim to increase the timely administration and avoid unnecessary or excessive use. Therefore, it is not intended to establish a legal standard of care. This document is based on consensus among perinatal experts throughout the world and serves as a guideline for use in clinical practice.
本实践指南遵循世界围产医学协会与围产医学基金会合作的使命,汇集了世界各地的团体和个人,旨在改善产前皮质类固醇(ACS)在胎儿成熟方面的应用。实际上,本文件为医疗保健从业者提供了关于 ACS 合理使用的进一步指导,目的是增加及时给药并避免不必要或过度使用。因此,它并非旨在确立护理的法定标准。本文件基于世界各地围产专家的共识,是临床实践中使用的指南。